<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab: Positive Topline Results in Phase III-CASSIOPEIA]]></title><description><![CDATA[<p dir="auto">Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma:</p>
<p dir="auto"><a href="https://ir.genmab.com/news-releases/news-release-details/genmab-announces-positive-topline-results-phase-iii-cassiopeia/?fbclid=IwAR3UjCGA7O6fnfoanEJHHsKg6jC-tpdnoYFunXbOqJgBRIClqYQiZPZs0Xc" rel="nofollow ugc">https://ir.genmab.com/news-releases/news-release-details/genmab-announces-positive-topline-results-phase-iii-cassiopeia/?fbclid=IwAR3UjCGA7O6fnfoanEJHHsKg6jC-tpdnoYFunXbOqJgBRIClqYQiZPZs0Xc</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/439917/genmab-positive-topline-results-in-phase-iii-cassiopeia</link><generator>RSS for Node</generator><lastBuildDate>Fri, 17 Jul 2026 04:30:25 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/439917.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 22 Oct 2018 03:26:37 GMT</pubDate><ttl>60</ttl></channel></rss>